PGM2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.643400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.817200E-01
Normal-vs-Stage2
8.480200E-01
Normal-vs-Stage3
2.839400E-01
Normal-vs-Stage4
2.264000E-01
Stage1-vs-Stage2
5.121000E-01
Stage1-vs-Stage3
4.698400E-01
Stage1-vs-Stage4
1.389620E-01
Stage2-vs-Stage3
1.969440E-01
Stage2-vs-Stage4
2.435200E-01
Stage3-vs-Stage4
3.848300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.999000E-01
Normal-vs-AfricanAmerican
6.336000E-01
Normal-vs-Asian
9.929800E-01
Caucasian-vs-AfricanAmerican
3.213800E-01
Caucasian-vs-Asian
9.855000E-01
AfricanAmerican-vs-Asian
4.869800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.954200E-01
Normal-vs-Female
9.086000E-01
Male-vs-Female
6.459800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.240200E-01
Normal-vs-Age(41-60Yrs)
6.132000E-01
Normal-vs-Age(61-80Yrs)
8.637400E-01
Normal-vs-Age(81-100Yrs)
6.318800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.241800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.983600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.230600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.322370E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.156190E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.351000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.214800E-01
Normal-vs-Daily Drinker
5.387600E-01
Normal-vs-Weekly Drinker
8.435600E-01
Normal-vs-Occasional Drinker
6.382200E-01
Normal-vs-Social Drinker
8.900600E-01
Non Drinker-vs-Daily Drinker
4.043200E-01
Non Drinker-vs-Weekly Drinker
9.437400E-01
Non Drinker-vs-Occasional Drinker
1.374000E-01
Non Drinker-vs-Social Drinker
4.928200E-01
Daily Drinker-vs-Weekly Drinker
4.369600E-01
Daily Drinker-vs-Occasional Drinker
4.807700E-02
Daily Drinker-vs-Social Drinker
1.743990E-01
Weekly Drinker-vs-Occasional Drinker
2.463800E-01
Weekly Drinker-vs-Social Drinker
5.805400E-01
Occasional Drinker-vs-Social Drinker
4.700800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.597800E-01
Normal-vs-Grade 2
2.235000E-01
Normal-vs-Grade 3
1.463430E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.742300E-02
Grade 1-vs-Grade 3
3.300900E-03
Grade 1-vs-Grade 4
7.597800E-01
Grade 2-vs-Grade 3
2.648000E-01
Grade 2-vs-Grade 4
2.235000E-01
Grade 3-vs-Grade 4
1.463430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.825400E-01
Normal-vs-NonDiabetic
9.574200E-01
Diabetic-vs-NonDiabetic
5.460200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.342600E-01
Normal-vs-NoPancreatitis
9.418000E-01
Pancreatitis-vs-NoPancreatitis
6.720400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.922400E-01
Normal-vs-N1
8.382200E-01
N0-vs-N1
1.222780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.645000E-01
Normal-vs-TP53-NonMutant
5.696800E-01
TP53-Mutant-vs-TP53-NonMutant
1.634280E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
